Detalles de la búsqueda
1.
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
Immunity
; 53(5): 925-933.e4, 2020 11 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-33129373
2.
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States.
Clin Infect Dis
; 76(3): e460-e468, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35580849
3.
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
J Infect Dis
; 225(10): 1694-1700, 2022 05 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34932114
4.
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
Clin Infect Dis
; 74(9): 1515-1524, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34358310
5.
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
Clin Infect Dis
; 75(Suppl 2): S159-S166, 2022 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675695
6.
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1327-1334, 2022 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264830
7.
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021.
MMWR Morb Mortal Wkly Rep
; 71(4): 118-124, 2022 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085218
8.
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative Study.
Clin Infect Dis
; 73(8): 1459-1468, 2021 10 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014274
9.
Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)-United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
Clin Infect Dis
; 73(Suppl 1): S32-S37, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33977301
10.
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.
MMWR Morb Mortal Wkly Rep
; 70(38): 1337-1343, 2021 Sep 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-34555004
11.
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
MMWR Morb Mortal Wkly Rep
; 70(34): 1156-1162, 2021 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-34437524
12.
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
JAMA
; 326(20): 2043-2054, 2021 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34734975
13.
Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities - United States, July 2020.
MMWR Morb Mortal Wkly Rep
; 69(36): 1258-1264, 2020 Sep 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32915165
14.
Telework Before Illness Onset Among Symptomatic Adults Aged ≥18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities - United States, July 2020.
MMWR Morb Mortal Wkly Rep
; 69(44): 1648-1653, 2020 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33151918
15.
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020.
MMWR Morb Mortal Wkly Rep
; 69(30): 993-998, 2020 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-32730238
16.
Bedside veno-venous ECMO cannulation: A pertinent strategy during the COVID-19 pandemic.
J Card Surg
; 35(6): 1180-1185, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32531129
17.
Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress.
Influenza Other Respir Viruses
; 16(4): 680-689, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35347854
18.
Clinical Severity and mRNA Vaccine Effectiveness for Omicron, Delta, and Alpha SARS-CoV-2 Variants in the United States: A Prospective Observational Study.
medRxiv
; 2022 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35169811
19.
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
BMJ
; 376: e069761, 2022 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35264324
20.
Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020.
Vaccine
; 39(37): 5271-5276, 2021 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34376307